Insulin adsorption to catheter materials used for intensive insulin therapy in critically ill patients: Polyethylene versus polyurethane - possible cause of variation in glucose control?

dc.bibliographicCitation.firstPage1eng
dc.bibliographicCitation.issue1eng
dc.bibliographicCitation.journalTitleOpen Critical Care Medicine Journaleng
dc.bibliographicCitation.volume7eng
dc.contributor.authorLey, S.C.
dc.contributor.authorAmmann, J.
dc.contributor.authorHerder, C.
dc.contributor.authorDickhaus, T.
dc.contributor.authorHartmann, M.
dc.contributor.authorKindgen-Milles, D.
dc.date.accessioned2020-11-12T07:22:14Z
dc.date.available2020-11-12T07:22:14Z
dc.date.issued2014
dc.description.abstractIntroduction: Restoring and maintaining normoglycemia by intensified insulin therapy in critically ill patients is a matter of ongoing debate since the risk of hypoglycemia may outweigh positive effects on morbidity and mortality. In this context, adsorption of insulin to different catheter materials may contribute to instability of glucose control. We studied the adsorption of insulin to different tubing materials in vitro and the effects on glycemic control in vivo. Materials and Methods: In vitro experiments: A syringe pump was filled with 50 IU insulin diluted to 50 ml saline. A flow of 2 ml/h was perfused through polyethylene (PET) or polyurethane (PUR) tubing. Insulin concentrations were measured at the end of the tube for 24 hours using Bradford's protein assay. In vivo study: In a randomized double-blinded cross-over design, 10 intensive care patients received insulin via PET and PUR tubes for 24 hours each, targeting blood glucose levels of 80-150 mg/dl. We measured blood glucose levels, the insulin dose required to maintain target levels, and serum insulin and C-peptide levels. Results: In vitro experiments: After the start of the insulin infusion, only 20% (median, IQR 20-27) (PET) and 22% (IQR 16-27) (PUR) of the prepared insulin concentration were measured at the end of the 2 meter tubing. Using PET, after one hour infusion the concentration increased to 34% (IQR 29-36) and did not increase significantly during the next 24 hours (39% (IQR 39-40)). Using PUR, higher concentrations were detected than for PET at every measurement from 1 hour (82% (IQR 70-86)) to 24 hours (79% (IQR 64-87)). In vivo study: Glycemic control was effective and not different between groups. Significantly higher volumes of insulin solution had to be infused with PET compared to PUR (median PET 70.0 (IQR 56-82) ml vs. PUR 42 (IQR 31-63) ml; p=0.0015). Serum insulin concentrations did not decrease significantly one hour after changing to PET or PUR tubing. Conclusion: Polyurethane tubing systems allow application of insulin with significantly lower adsorption rates than polyethylene tubing systems. As a consequence, less insulin solution has to be infused to patients for effective blood glucose control. Tubing material of the insulin infusion may be crucial for safe and effective glycemic control in critically ill patients.eng
dc.description.versionpublishedVersioneng
dc.identifier.urihttps://doi.org/10.34657/4540
dc.identifier.urihttps://oa.tib.eu/renate/handle/123456789/5911
dc.language.isoengeng
dc.publisherSharjah : Bentham Science Publishers B.V.eng
dc.relation.doihttps://doi.org/10.2174/1874828701407010001
dc.relation.issn1874-8287
dc.rights.licenseCC BY-NC 3.0 Unportedeng
dc.rights.urihttps://creativecommons.org/licenses/by-nc/3.0/eng
dc.subject.ddc610eng
dc.subject.otherAdsorptioneng
dc.subject.otherCritical illnesseng
dc.subject.otherHypoglycemiaeng
dc.subject.otherInsulineng
dc.subject.otherPolyethyleneeng
dc.subject.otherPolyurethaneeng
dc.subject.otherC peptideeng
dc.subject.othercatecholamineeng
dc.subject.otherdobutamineeng
dc.subject.otherinsulineng
dc.subject.otherneutral insulineng
dc.subject.othernoradrenalineng
dc.subject.otherpolyethyleneeng
dc.subject.otherpolyurethaneng
dc.subject.otherinsulineng
dc.subject.othershort acting insulineng
dc.subject.otheradulteng
dc.subject.otheragedeng
dc.subject.otherarticleeng
dc.subject.otherblood glucose monitoringeng
dc.subject.othercathetereng
dc.subject.otherclinical articleeng
dc.subject.othercomparative studyeng
dc.subject.otherconcentration (parameters)eng
dc.subject.othercritically ill patienteng
dc.subject.othercrossover procedureeng
dc.subject.otherdiabetes mellituseng
dc.subject.otherdouble blind procedureeng
dc.subject.otherdrug adsorptioneng
dc.subject.otherenzyme linked immunosorbent assayeng
dc.subject.otherfemaleeng
dc.subject.otherfluid balanceeng
dc.subject.otherglycemic controleng
dc.subject.otherhumaneng
dc.subject.otherhypoglycemiaeng
dc.subject.otherinfusion pumpeng
dc.subject.otherinsulin infusioneng
dc.subject.otherkidney failureeng
dc.subject.othermaleeng
dc.subject.othermiddle agedeng
dc.subject.otherpriority journaleng
dc.subject.otherrandomized controlled trialeng
dc.subject.othersyringeeng
dc.subject.othertubeeng
dc.subject.othervery elderlyeng
dc.subject.otherArticleeng
dc.subject.otherdisease severityeng
dc.subject.otherglucose blood leveleng
dc.subject.otherhypoglycemiaeng
dc.subject.otherinsulin blood leveleng
dc.subject.otherinsulin treatmenteng
dc.subject.otherscoring systemeng
dc.titleInsulin adsorption to catheter materials used for intensive insulin therapy in critically ill patients: Polyethylene versus polyurethane - possible cause of variation in glucose control?eng
dc.typeArticleeng
dc.typeTexteng
tib.accessRightsopenAccesseng
wgl.contributorWIASeng
wgl.subjectMedizin, Gesundheiteng
wgl.typeZeitschriftenartikeleng
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ley2014.pdf
Size:
223.53 KB
Format:
Adobe Portable Document Format
Description:
Collections